Pubmed ID |
Author |
Year |
Title |
23948280
|
Hacivelioglu S
|
2013
|
Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
|
23948452
|
Wiser A
|
2013
|
Age-related normogram for antral follicle count in women with polycystic ovary syndrome.
|
23951943
|
Minagawa K
|
2013
|
[Characteristics of women with epilepsy who developed polycystic ovary syndrome owing to the therapy with valproate sodium].
|
23953589
|
Li Y
|
2013
|
Association of AQP8 in women with PCOS.
|
23956870
|
Capula C
|
2013
|
Predictors of postpartum glucose tolerance testing in italian women with gestational diabetes mellitus.
|
23957781
|
Shabir I
|
2013
|
Morning plasma cortisol is low among obese women with polycystic ovary syndrome.
|
23957782
|
Morgante G
|
2013
|
Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.
|
23958241
|
Ciaraldi TP
|
2013
|
Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
|
23960423
|
Saha L
|
2013
|
N-acetyl cysteine in clomiphene citrate resistant polycystic ovary syndrome: A review of reported outcomes.
|
23960719
|
Khalaf BH
|
2010
|
Leptin levels in relation to marital status and neuroendocrine function in Iraqi females with polycystic ovary syndrome.
|
23961469
|
Bajaj S
|
2013
|
South Asian women with diabetes: Psychosocial challenges and management: Consensus statement.
|
23961484
|
Ahmadi A
|
2013
|
Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome.
|
23961784
|
Enli Y
|
2013
|
Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
|
23969185
|
Georgopoulos NA
|
2013
|
Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
|
23971241
|
Check JH
|
2013
|
Dihydrotestosterone may contribute to the development of migraine headaches.
|
23971253
|
Vaggopoulos V
|
2013
|
The prevalence of phenotypic subgroups in Greek women with polycystic ovarian syndrome.
|
23975191
|
Deepika ML
|
2013
|
TNF-? haplotype association with polycystic ovary syndrome - a South Indian study.
|
23977829
|
Schrager S
|
2013
|
Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease.
|
23978544
|
August P
|
2013
|
Hypertension in women.
|
23979790
|
Li S
|
2013
|
The expression of 11?-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
|
23979947
|
Mahran A
|
2013
|
The predictive value of circulating anti-M?llerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
|
23980058
|
Zhang X
|
2013
|
Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
|
23980352
|
Chen Y
|
2013
|
[Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
|
23980726
|
Sahmay S
|
2013
|
Elevated serum levels of anti-M?llerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
|
23981122
|
Yilmaz ?
|
2013
|
The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS.
|
23981769
|
Morotti E
|
2013
|
Body imaging and sexual behavior in lean women with polycystic ovary syndrome.
|
23988170
|
Velija-A?imi Z
|
2013
|
Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment.
|
23994294
|
Shen W
|
2013
|
Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
|
23994667
|
Rochester JR
|
2013
|
Bisphenol A and human health: a review of the literature.
|
23996806
|
Erdo?an E
|
2013
|
Subclinical left ventricular dysfunction in women with polycystic ovary syndrome: an observational study.
|
23998514
|
Ates S
|
2013
|
Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics.
|
23999280
|
Barr S
|
2013
|
An isocaloric low glycemic index diet improves insulin sensitivity in women with polycystic ovary syndrome.
|
24001418
|
Pavi?i? Baldani D
|
2013
|
Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
|
24001751
|
Arusoglu G
|
2013
|
Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
|
24002401
|
Livadas S
|
2013
|
Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach.
|
24002402
|
Catteau-Jonard S
|
2013
|
Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism.
|
24002403
|
Barber TM
|
2013
|
Genetics of polycystic ovary syndrome.
|
24002404
|
Carmina E
|
2013
|
Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome.
|
24002405
|
Macut D
|
2013
|
Dyslipidemia and oxidative stress in PCOS.
|
24002406
|
Bajuk Studen K
|
2013
|
Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
|
24002407
|
Pasquali R
|
2013
|
Insulin sensitizers in polycystic ovary syndrome.
|
24002408
|
Unluhizarci K
|
2013
|
Hirsutism - from diagnosis to use of antiandrogens.
|
24002409
|
Bozdag G
|
2013
|
Combined oral contraceptives in polycystic ovary syndrome - indications and cautions.
|
24002410
|
Panidis D
|
2013
|
Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery.
|
24002411
|
Alexandraki KI
|
2013
|
Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype.
|
24002412
|
Pignatelli D
|
2013
|
Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
|
24005592
|
Joe-kechebelu NN
|
2013
|
Familial trend in polycystic ovarian syndrome: report of two cases.
|
24009134
|
Dunaif A
|
2013
|
Renaming PCOS--a two-state solution.
|
24013985
|
Schwetz V
|
2014
|
Osteocalcin levels on oral glucose load in women being investigated for polycystic ovary syndrome.
|
24014214
|
Ghanem ME
|
2013
|
Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial.
|
24014601
|
Anand-Ivell R
|
2013
|
Circulating insulin-like factor 3 (INSL3) in healthy and infertile women.
|
24014605
|
Comim FV
|
2013
|
Increased protein expression of LHCG receptor and 17?-hydroxylase/17-20-lyase in human polycystic ovaries.
|
24014819
|
Rothman M
|
2013
|
PCOS: what teens need to know.
|
24020909
|
Di Carlo C
|
2013
|
Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study.
|
24020937
|
Guleria AK
|
2014
|
Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
|
24023577
|
Kuang H
|
2013
|
Acupuncture and clomiphene citrate for live birth in polycystic ovary syndrome: study design of a randomized controlled trial.
|
24023708
|
Bungum L
|
2013
|
The circadian variation in Anti-M?llerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.
|
24024320
|
Yu L
|
2013
|
Effects of electroacupuncture and Chinese kidney-nourishing medicine on polycystic ovary syndrome in obese patients.
|
24026057
|
Lebbe M
|
2013
|
Involvement of androgens in ovarian health and disease.
|
24030183
|
Medeiros SF
|
2013
|
New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients.
|
24031110
|
Samsami Dehaghani A
|
2013
|
Anti-Nuclear Antibodies in Patients with Polycystic Ovary Syndrome before and after Laparoscopic Electrocauterization.
|
24032264
|
Brzozowska M
|
2013
|
[The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders].
|
24032272
|
Milewski R
|
2013
|
[Analysis of the demographic profile of patients treated for infertility using assisted reproductive techniques in 2005-2010].
|
24034940
|
Michaliszyn SF
|
2013
|
Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile.
|
24036000
|
Jimenez PT
|
2013
|
DHEA-mediated inhibition of the pentose phosphate pathway alters oocyte lipid metabolism in mice.
|
24037889
|
Murri M
|
2013
|
Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression.
|
24040195
|
Chakraborty P
|
2013
|
Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.
|
24040456
|
Yang J
|
2013
|
The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome.
|
24044903
|
Krul-Poel YH
|
2013
|
The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review.
|
24045781
|
Kawada T
|
2013
|
Sleep efficiency in patients with polycystic ovarian syndrome.
|
24045782
|
Shreeve N
|
2013
|
Reply: sleep efficiency in patients with polycystic ovarian syndrome.
|
24051942
|
Cappelli V
|
2013
|
[Evaluation of a new association between insulin-sensitizers and ?-lipoic acid in obese women affected by PCOS].
|
24052006
|
Yum KS
|
2013
|
Pattern of voiding dysfunction after acute brainstem infarction.
|
24056171
|
Thompson IR
|
2014
|
GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression.
|
24057296
|
Lauria PB
|
2013
|
Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
|
24064685
|
Welt CK
|
2013
|
Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.
|
24068296
|
Strowitzki T
|
2013
|
In vitro maturation (IVM) of human oocytes.
|
24069859
|
Nawrocka-Rutkowska J
|
2013
|
Insulin resistance assessment in patients with polycystic ovary syndrome using different diagnostic criteria--impact of metformin treatment.
|
24073009
|
Johansson J
|
2013
|
Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction.
|
24077439
|
Veiga-Lopez A
|
2014
|
Developmental programming: postnatal estradiol amplifies ovarian follicular defects induced by fetal exposure to excess testosterone and dihydrotestosterone in sheep.
|
24078159
|
El-Shal AS
|
2013
|
Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome.
|
24079935
|
Hara S
|
2013
|
Pioglitazone counteracts the tumor necrosis factor-? inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture system.
|
24081730
|
Joham AE
|
2014
|
Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
|
24082083
|
Kawamura K
|
2013
|
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment.
|
24082649
|
Kar S
|
2013
|
Current evidence supporting letrozole for ovulation induction.
|
24084835
|
Nohara K
|
2013
|
Developmental androgen excess disrupts reproduction and energy homeostasis in adult male mice.
|
24086769
|
Eriksen MB
|
2013
|
Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS).
|
24087928
|
Insenser M
|
2013
|
Proteomics and polycystic ovary syndrome.
|
24091229
|
Bostedt H
|
2013
|
[Clinical and endocrinological findings of bitches with ovarian cyst syndrome].
|
24092830
|
Domecq JP
|
2013
|
Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.
|
24092831
|
Brower M
|
2013
|
The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS.
|
24092832
|
Domecq JP
|
2013
|
Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis.
|
24095114
|
Engeland WC
|
2013
|
Sensitization of endocrine organs to anterior pituitary hormones by the autonomic nervous system.
|
24096951
|
Horn M
|
2013
|
Polycystic ovary syndrome in adolescents: (women's health series).
|
24098506
|
Meng Y
|
2013
|
Downregulated expression of peroxiredoxin 4 in granulosa cells from polycystic ovary syndrome.
|
24099797
|
Khalil RA
|
2013
|
Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
|
24101226
|
Huddleston HG
|
2013
|
Biomarkers of ovarian reserve in women with polycystic ovary syndrome.
|
24101529
|
Siristatidis CS
|
2013
|
In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
|
24102267
|
Kulshreshtha B
|
2013
|
Family background of Diabetes Mellitus, obesity and hypertension affects the phenotype and first symptom of patients with PCOS.
|
24102794
|
Saranya K
|
2014
|
Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome.
|